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ABSTRACT The cell wall of Staphylococcus aureus is composed of peptidoglycan
and the anionic polymers lipoteichoic acid (LTA) and wall teichoic acid. LTA is re-
quired for growth and normal cell morphology in S. aureus. Strains lacking LTA are
usually viable only when grown under osmotically stabilizing conditions or after the
acquisition of compensatory mutations. LTA-negative suppressor strains with inacti-
vating mutations in gdpP, which resulted in increased intracellular c-di-AMP levels,
were described previously. Here, we sought to identify factors other than c-di-AMP
that allow S. aureus to survive without LTA. LTA-negative strains able to grow in un-
supplemented medium were obtained and found to contain mutations in sgtB, mazE, clpX,
or vraT. The growth improvement through mutations in mazE and sgtB was con-
firmed by complementation analysis. We also showed that an S. aureus sgtB trans-
poson mutant, with the monofunctional peptidoglycan glycosyltransferase SgtB
inactivated, displayed a 4-fold increase in the MIC of oxacillin, suggesting that al-
terations in the peptidoglycan structure could help bacteria compensate for the lack
of LTA. Muropeptide analysis of peptidoglycans isolated from a wild-type strain and
sgtB mutant strain did not reveal any sizable alterations in the peptidoglycan struc-
ture. In contrast, the peptidoglycan isolated from an LTA-negative ltaS mutant strain
showed a significant reduction in the fraction of highly cross-linked peptidoglycan,
which was partially rescued in the sgtB ltaS double mutant suppressor strain. Taken
together, these data point toward an important function of LTA in cell wall integrity
through its necessity for proper peptidoglycan assembly.
IMPORTANCE The bacterial cell wall acts as a primary defense against environmen-
tal insults such as changes in osmolarity. It is also a vulnerable structure, as defects
in its synthesis can lead to growth arrest or cell death. The important human patho-
gen Staphylococcus aureus has a typical Gram-positive cell wall, which consists of
peptidoglycan and the anionic polymers LTA and wall teichoic acid. Several clinically
relevant antibiotics inhibit the synthesis of peptidoglycan; therefore, it and teichoic
acids are considered attractive targets for the development of new antimicrobials.
We show that LTA is required for efficient peptidoglycan cross-linking in S. aureus
and inactivation of a peptidoglycan glycosyltransferase can partially rescue this de-
fect, together revealing an intimate link between peptidoglycan and LTA synthesis.
KEYWORDS Staphylococcus aureus, cell wall, lipoteichoic acid
Staphylococcus aureus is a Gram-positive bacterium found as a commensal on theskin and in nasal passages of healthy individuals. However, this bacterium is also an
important human pathogen causing hospital-acquired and community-acquired infec-
tions, such as serious skin infections, osteomyelitis, and endocarditis (1–3). Of major
concern is the increasing resistance of this organism to a large number of clinically
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relevant antibiotics (4). A number of virulence factors contribute to successful host
colonization, immune evasion, and acquisition of nutrients within the host (5). Many of
these factors are either secreted proteins or other extracellular proteins closely asso-
ciated with the bacterial cell envelope (6).
The cell envelope is essential for bacterial survival and pathogenesis but also is a
target of a number of important antimicrobials. It functions as a barrier and protects
bacteria from environmental insults but at the same time needs to allow the passage
of solutes and nutrients, as well as sensing of changes in the external environment (7).
S. aureus has a typical Gram-positive cell envelope, which consists of a cytoplasmic
membrane surrounded by a thick peptidoglycan layer (8). The peptidoglycan layer is a
dynamic macromolecular structure that undergoes constant cycles of polymerization
and hydrolysis to allow bacteria to grow and to divide (7). It is composed of glycan
chains made of alternating N-acetylglucosamine and N-acetylmuramic acid residues
connected by peptide bridges (9). This mesh-like sacculus is able to protect the cell
from environmental threats while withstanding the high internal osmotic pressure (10).
The final steps of peptidoglycan synthesis are catalyzed by enzymes termed penicillin-
binding proteins (PBPs), and coordinated actions of these enzymes are crucial for cell
survival (11). PBPs with glycosyltransferase and transpeptidase activities polymerize the
glycan chains and form peptide cross-bridges, while monofunctional transpeptidases
have only the former activity (11).
S. aureus encodes four PBPs, of which PBP1, which has transpeptidase activity, and
the bifunctional PBP2, which has transpeptidase and glycosyltransferase activities, are
the minimal requirements for cell survival (12). In methicillin-resistant S. aureus (MRSA)
strains, the alternative PBP2A, which has transpeptidase activity, is needed for -lactam
resistance, in addition to the glycosyltransferase activity of PBP2 (13, 14). Moreover,
additional nonessential proteins that are involved in peptidoglycan synthesis, such as
the monofunctional glycosyltransferases SgtA and SgtB (also named Mgt), have been
identified (12). Previous studies have shown that, although SgtA and SgtB have
glycosyltransferase activity in vitro, only SgtB can support the growth of S. aureus in the
absence of the main glycosyltransferase PBP2. SgtB alone, however, cannot support the
growth of S. aureus in the presence of -lactam antibiotics when an interaction
between PBP2 and PBP2A is needed (15, 16).
In Gram-positive bacteria, the peptidoglycan layer is interspersed with a plethora of
proteins and cell wall polymers named teichoic acids (17). Teichoic acids are further
categorized into lipoteichoic acid (LTA), which is anchored to the outer leaflet of the
cytoplasmic membrane via a lipid moiety, and wall teichoic acid (WTA), which is
covalently attached to the peptidoglycan (18). Teichoic acids form an important part of
the cell wall and contribute to the physical and chemical properties of the cell wall and
to the binding of divalent cations (19, 20). While both WTA and LTA are polyanionic cell
wall polymers, they are synthesized through separate independent pathways in S.
aureus and many other Gram-positive bacteria (21, 22). Consistent with this, our work
on the Gram-positive pathogen Listeria monocytogenes has revealed that LTA synthesis
is not abrogated in the absence of WTA and vice versa (23). Recent work using
pathway-specific inhibitors and a gene interaction screen provided further evidence
that the polymers not only are synthesized through separate pathways but also have
distinct functions in S. aureus (24).
LTA is an anionic polymer that in S. aureus is composed of glycerolphosphate
repeating units, which are further decorated with D-alanine residues and, under high
salt conditions, also with N-acetylglucosamine residues, as shown recently (25, 26).
Most proteins required for LTA synthesis have been identified and extensively studied
over the years (22, 27). One of the key enzymes required for LTA synthesis is the LTA
synthase enzyme LtaS (28, 29); this enzyme polymerizes the LTA backbone chain on the
outside of the cell, using the glycerolphosphate head group of the membrane lipid
phosphatidylglycerol as the substrate (29, 30). LTA is indispensable for the growth of S.
aureus under standard laboratory growth conditions, which highlights its important
physiological role (29, 31).
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Previous studies indicated functions for LTA in helping to direct the cell division
machinery (32), in controlling autolysin activity (31), in facilitating biofilm formation
(33), in mediating interactions with host cell receptors (17), in controlling susceptibility
and/or resistance to antimicrobial peptides, and in maintaining cation homeostasis (20).
S. aureus ltaS mutants, which lack the complete LTA polymer, can be constructed in
some strain backgrounds at low growth temperatures (31). It has also been shown that
LTA-deficient S. aureus strains are viable when grown under osmotically stabilizing
conditions in medium containing 7.5% NaCl or 40% sucrose (31, 34). However, the
bacteria display severe morphological defects, including increased cell size, clustering,
and cell division defects, even under conditions permissive for growth (34). Bacteria can
also readily acquire compensatory mutations, allowing them to grow in unsupple-
mented medium and improving their morphological defects (34). The majority of
compensatory mutations previously observed were in gdpP, leading to inactivation of
the c-di-AMP phosphodiesterase GdpP (34). The resulting increase in cellular c-di-AMP
levels allowed the bacteria to survive the cell wall stress caused by the absence of LTA,
which is now thought to be due to changes in the osmotic balance in the cell (34).
However, compensatory mutations that rescued the growth of an LTA-negative S.
aureus strain were found not only in gdpP but also in other genes (34).
As part of the current study, we sought to identify these genes and to further
characterize the encoded proteins, to gain additional insight into why LTA is essential
for the growth of S. aureus and potentially to uncover novel cellular functions for
proteins involved in cell wall assembly or maintenance. Using a suppressor screen
approach, we found that inactivation of the monofunctional peptidoglycan glycosyl-
transferase SgtB allowed S. aureus to grow in the absence of LTA. We further showed
that peptidoglycan cross-linking was significantly reduced in the absence of LTA and
could be partially restored upon inactivation of SgtB. This might strengthen the
peptidoglycan layer and thus contribute to the observed growth rescue.
RESULTS
Identification of S. aureus suppressor strains able to grow in the absence of
LTA in a c-di-AMP-independent way. LTA-deficient S. aureus strains are viable when
grown under osmotically stabilizing conditions in medium containing 7.5% NaCl or 40%
sucrose or in unsupplemented medium after the acquisition of compensatory muta-
tions (31, 34). The majority of compensatory mutations observed previously were in
gdpP, leading to inactivation of the c-di-AMP phosphodiesterase GdpP (34). In the same
study, suppressor strains with mutations outside the gdpP gene were noted (34). In
order to characterize suppressor strains with mutations in genes other than gdpP and
to gain further insight into the cellular function of LTA, a larger suppressor screen was
performed and the ltaS mutant LAC*ΔltaS::erm strains constructed in medium supple-
mented with either sucrose or NaCl were plated on unsupplemented tryptic soy agar
(TSA) plates. A number of independently obtained suppressor colonies were subse-
quently passed four times in fresh tryptic soy broth (TSB) to further improve their
growth. Next, the chromosomal DNA was isolated from 80 suppressor strains, and those
lacking mutations in gdpP (coding for the c-di-AMP hydrolase) and dacA (coding for the
c-di-AMP cyclase enzyme) were identified by determining the sequences of these two
genes. Of 80 colonies screened, no strains had mutations in dacA and 17 strains had no
mutation in gdpP, 7 of which were selected for further analysis. The absence of LTA and
the presence of WTA in the suppressor strains were confirmed by Western blotting and
Alcian blue/silver staining analysis, respectively (Fig. 1A and B). Next, the relative cellular
c-di-AMP levels in the different strains were determined using a previously described
competitive enzyme-linked immunosorbent assay (ELISA) (35, 36) (Fig. 1C). In contrast
to the gdpP mutant and the LTA-negative suppressor strain with a mutation in gdpP,
which showed the expected increase in c-di-AMP levels, the 7 suppressor strains chosen
for further analysis did not show an increase in cellular c-di-AMP concentrations
(Fig. 1C).
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Identification of genomic alterations in the S. aureus suppressor strains able to
grow in the absence of LTA. Next, the genomic sequences of the 7 suppressor strains
were determined and compared to that of the original ltaS mutant strains by using a
whole-genome sequencing approach. Mutations were found in sgtB (SAUSA300_1855),
coding for the monofunctional glycosyltransferase SgtB, and mutations in this gene
arose independently in 3 suppressor strains (Table 1). Another strain had a mutation in
SAUSA300_1254, coding for a hypothetical membrane protein, and SAUSA300_RS11150, en-
coding MazE, the antitoxin component of a type II toxin-antitoxin module (Table 1). In
the original study by Corrigan et al. (34), mutations found in SAUSA300_1254 were
proposed to be accessory and required to further improve the growth of the gdpP
mutant suppressor strains. Consistent with a previous report (2), a large deletion in clpX
(SAUSA300_1621), encoding a protein forming part of an ATP-dependent protease, was
observed in one strain (Table 1). Finally, a mutation in vraT (SAUSA300_1867), coding
for the membrane protein VraT and forming part of the VraRST three-component
system, was identified. Using our standard genome sequence analysis workflow, an
unusually large number (300) of zero-coverage regions were obtained for suppressor
strain S6, preventing us from matching a single-nucleotide polymorphism to the
FIG 1 Detection of LTA by Western blotting, WTA by Alcian blue/silver staining, and c-di-AMP by using
a competitive ELISA method. (A) Detection of LTA by Western blotting. Cell extracts were prepared from
LAC* (WT strain), an ltaS mutant strain (strain ANG2135), and the 7 ltaS suppressor strains (strains S1 to
S4 and S6 to S8) and separated on a 15% polyacrylamide gel. LTA was subsequently detected by Western
blotting using a polyglycerolphosphate-specific monoclonal antibody. A representative result from three
independent experiments is shown. (B) Visualization of WTA by native PAGE. WTAs were isolated from
the same strains as shown in panel A and separated on a 20% native gel. Bands were visualized with
Alcian blue staining and subsequently silver staining. One representative result from four independent
experiments is shown. (C) c-di-AMP detection by competitive ELISA. Cytoplasmic extracts were prepared
from LAC* (WT strain), the high-c-di-AMP-level control strains LAC* gdpP::kan (gdpP) and US3 (ltaS gdpP),
and the 7 ltaS suppressor strains (strains S1 to S4 and S6 to S8). c-di-AMP amounts were determined and
compared to those of the WT strain by ELISA. Of note, because this was a competitive ELISA, lower A490
readings were obtained for samples with higher c-di-AMP levels. The A490 reading obtained for the
sample derived from the WT strain was set to 100%, and percentage values were calculated for the test
strains. The average percentage values and SDs from three independent experiments (with three
technical replicates) are plotted.
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observed growth rescue with high confidence. Therefore, suppressor strain S6 is not
listed in Table 1 and was not analyzed further. The mutations identified in the other
suppressor strains were subsequently confirmed by fluorescent automated resequenc-
ing of the respective genomic region. Some of the observed mutations in sgtB, as well
as the mutations in vraT, clpX, and mazE, resulted in frameshift mutations and intro-
duction of premature stop codons, suggesting that the absence of the encoded
proteins compensates for the lack of LTA.
Phenotypic characterization of the LTA-negative S. aureus suppressor strains.
In a previous study, it was shown that S. aureus cells can grow without LTA in the
absence of ClpX (2); therefore, we did not further characterize the clpX mutant sup-
pressor strain obtained as part of this study. Instead, our analysis focused on suppressor
strains with mutations in novel genes, i.e., strains with mutations in mazE, sgtB, or vraT.
MazE, the antitoxin component of a type II toxin-antitoxin module and whose is part of
the sigB regulon, has been shown to be essential for full activity of the alternative sigma
factor SigB (37). SigB and members of its regulon enable bacteria to respond rapidly to
environmental and antibiotic stresses and also play a role in cell envelope homeostasis
(38, 39). Various studies have investigated the role of the VraTSR three-component
regulatory system, and this system has been reported to be involved in the induction
of the cell wall stressosome, mainly in the presence of cell wall-targeting antibiotics
(40–42). Interestingly, the monofunctional glycosyltransferase SgtB, which was also
identified as part of our screen, is one of the proteins belonging to the cell wall
stressosome whose expression is regulated by VraTSR independent of the presence of
cell wall-targeting antibiotics (40). To further characterize the suppressor strains, we
first confirmed the growth improvement of strains S2-mazE, S4-sgtB, and S7-vraT when
they were propagated in TSB. All 3 suppressor strains grew better than the original ltaS
mutant strain, and their growth rate was only slightly reduced, compared to that of the
wild-type (WT) LAC* strain (Fig. 2A). Next, the cell morphology of the WT strain, the
original ltaSmutant, and the 3 suppressor strains was assessed by microscopy following
staining of the peptidoglycan with fluorescently labeled vancomycin. The cell morphol-
ogy of the suppressor strains was considerably improved; in particular, for suppressor
strain S2-mazE, the division site was correctly placed in most cells (Fig. 2B). Next, the
susceptibility of the suppressor strains to a number of cell wall-targeting antibiotics was
determined. Although the growth and cell morphology of the suppressor strains were
improved, the strains remained hypersensitive to the -lactam antibiotic oxacillin, with
MICs reduced 32-fold for the different suppressor strains, compared to the WT LAC*
strain (Fig. 3A). The susceptibility to the cell wall- or membrane-targeting antibiotics
lysostaphin, nisin, vancomycin, and daptomycin was also tested, but no drastic differ-
ences were observed (Table 2). Finally, the growth of the 3 different suppressor strains
was assessed on plates containing Congo red. Congo red is an anionic azo dye
traditionally used for the detection of biofilms in Staphylococcus. At higher concentra-
tions, however, it inhibits the growth of S. aureus, and it has been used in the past to
indicate differences in the cell wall integrity of different S. aureus strains (43). Recently,
the target of Congo red was established as the LTA synthase enzyme LtaS (44).
Therefore, our suppressor strains, which have ltaS deletions and are able to grow in the
absence of LTA, should be resistant to this dye. To test the susceptibility of the
suppressor strains, serial dilutions of overnight cultures were spotted on TSA plates
containing 0.1% Congo red (Fig. 2C). The suppressor strains carrying mutations in mazE
and sgtB were significantly more resistant to Congo red than was the WT strain,
indicating that inactivation of either one of these genes is indeed sufficient to bypass
the LTA requirement. However, the suppressor strain with a mutation in vraT grew
poorly on the Congo red plates, suggesting that this strain might not be a true
suppressor strain.
Introduction of SgtB or MazE in the respective suppressor strain results in the
expected growth arrest. The results of the whole-genome sequencing analysis
suggested that inactivation of MazE or SgtB was sufficient to allow S. aureus to grow
in the absence of LTA. Introduction of a WT copy of mazE or sgtB into the respective
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suppressor strain should restore this phenotype and be lethal for the suppressor
strains when they are grown in unsupplemented medium but should not have an
effect when the bacteria are propagated in medium supplemented with 40%
sucrose. In order to test this, plasmids piTET-mazE and piTET-sgtB, allowing for
anhydrotetracycline (Atet)-inducible gene expression, were introduced into the
respective suppressor strains. As controls, these plasmids were also introduced into
the WT LAC* strain. Serial dilutions of these different strains were spotted onto TSA
plates containing 100 ng/ml or 200 ng/ml Atet, for mazE or sgtB expression, respec-
tively. As expected for successful complementation, the expression of mazE pre-
vented the growth of the suppressor strain S2-mazE (Fig. 4A) and the expression of
sgtB prevented the growth of the suppressor strain S4-sgtB (Fig. 4B) on TSA but they
had no effect when the bacteria were spotted on medium supplemented with 40%
sucrose (Fig. 5). Of note, the mazE suppressor strain S2-mazE contained an addi-
tional mutation in a gene coding for a membrane protein of unknown function with
locus tag SAUSA300_1254. Introduction of a WT copy of this gene into the sup-
pressor strain did not prevent the growth of this suppressor strain (data not shown).
Taken together, the results of this complementation analysis support the notion
that inactivation of SgtB or MazE is sufficient to allow S. aureus to grow in the
absence of LTA.
FIG 2 Growth and cell morphology of WT and mutant S. aureus strains. (A) Bacterial growth curves. LAC*
(WT strain) and the suppressor strains S2-mazE, S4-sgtB, and S7-vraT were grown overnight in TSB, and
the original ltaS mutant strain (ANG2135) was grown in TSB with 40% sucrose. The next day, bacterial
cells were washed and diluted in TSB to an OD600 of 0.05, and the bacterial growth was subsequently
monitored over a period of 10 h. The average OD600 readings from three experiments were plotted. (B)
Microscopic analysis. Bacterial cells from overnight cultures of the same strains as used in panel A were
washed, back-diluted, and grown to mid-log phase in TSB or TSB with 40% sucrose, as indicated. The
bacterial cells were subsequently stained with BODIPY-vancomycin and analyzed by fluorescence
microscopy. (C) Analysis of bacterial growth on Congo red-containing TSA plates. Overnight cultures of
the WT strain and the indicated suppressor strains were serially diluted and spotted on TSA plates
supplemented with 0.1% Congo red, and the plates were incubated for 48 h at 37˚C. For panels B and
C, representative results of three independent experiments are shown.
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Growth characterization and antibiotic resistance of an S. aureus LAC* sgtB
mutant. Inactivation of MazE likely has pleotropic effects due to its involvement in the
activity of the alternative sigma factor SigB, and the reason why its inactivation allows
S. aureus to grow in the absence of LTA could be indirect. Therefore, we next focused
on trying to gain a better understanding of the cellular function of the monofunctional
peptidoglycan glycosyltransferase SgtB and how its inactivation allows S. aureus to
survive in the absence of LTA. To this end, the sgtB mutant strain LAC*sgtB::tn was
constructed by moving the genomic region with a transposon insertion in sgtB from the
Nebraska transposon mutant library strain NE596 (45) into the LAC* background. SgtB
is one of two monofunctional peptidoglycan glycosyltransferases encoded in the S.
aureus genome, and the protein can polymerize peptidoglycan chains in vitro (46).
Although it is dispensable for the growth of S. aureus, SgtB becomes necessary for
bacterial survival in the absence of the main glycosyltransferase PBP2 (12, 15, 47).
Consistent with these previous observations, no differences in the cell growth and
morphology of the sgtB mutant S. aureus strain LAC*sgtB::tn, compared to the WT LAC*
FIG 3 Oxacillin MICs for WT and mutant S. aureus strains. Oxacillin MICs for LAC* (WT strain) and the
suppressor strains S2-mazE, S4-sgtB, and S7-vraT (A) and for LAC* (WT strain) and the LAC* sgtB::tnmutant
without an integrative plasmid (), with an integrative plasmid (pCL55), or with an integrative comple-
mentation plasmid (pCL55-sgtB) (B) are shown. Experiments were conducted with six biological repli-
cates. Medians and 95% confidence intervals of the oxacillin MIC for all strains are plotted. A Kruskal-
Wallis one-way analysis of variance test was performed, which indicated significant differences.
Subsequently, Dunn’s tests were performed, and the P values were corrected for the multiple compar-
isons against the WT strain. **, P  0.01; ***, P  0.001; n.s., not significant.
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strain, were observed (Fig. 6A and B). Our results indicate that inactivation of SgtB
allows S. aureus to survive in the absence of LTA; therefore, the sgtB mutant strain
should no longer be sensitive to the Congo red dye. To test this, serial dilutions of the
WT strain, the sgtB mutant, and a complementation strain were spotted on TSA plates
containing 0.1% Congo red, which inhibits the LtaS enzyme. Indeed, the sgtB mutant
strain was considerably more resistant to Congo red than was the WT strain, and this
phenotype could be complemented by introducing a functional copy of sgtB into the
mutant strain (Fig. 6C). Next, we also tested the susceptibility of the sgtB mutant and
the complementation strain to the cell wall-active antibiotics oxacillin, lysostaphin,
nisin, vancomycin, and daptomycin. While no differences in the susceptibility of the
sgtB mutant to most antibiotics, compared to the WT strain, were observed, a slight
(4-fold) and statistically significant increase in resistance to oxacillin was observed (Fig.
3B and Table 2). Taken together, these results indicate that, while no growth or clearly
visible morphological differences between the WT strain and the sgtB mutant strain
were observed, deletion of sgtB led to increased Congo red resistance and 4-fold
increased oxacillin resistance in our strain background.
Inactivation of SgtB leading to an increase in peptidoglycan cross-linking in an
LTA-negative S. aureus strain. Since SgtB is involved in peptidoglycan synthesis and
the sgtB mutant displayed slightly increased oxacillin resistance, we hypothesized that
sgtB deletion could somehow “strengthen” the cell wall through alterations in the
peptidoglycan structure. In order to investigate this, the muropeptide profiles of
peptidoglycan isolated from the WT LAC* strain, the sgtB mutant strain LAC*sgtB::tn,
and the ltaS sgtB mutant suppressor strain S4-sgtB were determined following the
growth of these strains in TSB. In addition, the muropeptide profiles for peptidoglycan
isolated from these three strains and from the original ltaS mutant strain were deter-
mined following growth in TSB supplemented with 40% sucrose (Fig. 7). The WT and
sgtB mutant strains showed very similar and typical S. aureus muropeptide profiles (Fig.
7A). The chemical structures of several muropeptide fragments in a number of these
peaks were determined previously in the seminal paper by de Jonge et al. (48). Where
possible, we numbered the peaks as described by de Jonge et al. (48), with peaks 1 to
5 being monomeric, peaks 9 to 14 dimeric, peak 15 trimeric, and peaks 16 and above
higher oligomeric muropeptide fragments. Quantification of the monomeric, dimeric,
trimeric, and higher oligomeric peptidoglycan fragments showed that the peptidogly-
can was highly cross-linked in both strains, with approximately 70% of the UV absorb-
ing material being found in the higher oligomeric fraction (Fig. 7B and C). No clear
differences in the muropeptide profiles of the WT strain and the sgtB mutant strain,
grown either in TSB or in TSB supplemented with 40% sucrose, were found (Fig. 7). In
contrast to the WT strain and the sgtBmutant strain, a decrease in the higher oligomeric
peptidoglycan material was observed for the ltaS suppressor strain S4-sgtB in both TSB
and TSB with sucrose (Fig. 7). Visual inspection of the chromatograms also indicated
that peak 12, corresponding to a currently unknown muropeptide, was reduced in S.
aureus strains unable to produce LTA, i.e., the original ltaS mutant strain and the S4-ltaS
suppressor strain (Fig. 7A). Perhaps most notably, comparison of the muropeptide
profiles of the peptidoglycan isolated from the original ltaS mutant strain and the ltaS
sgtB suppressor strain S4-sgtB after growth in TSB with sucrose showed that, while the
amount of cross-linked peptidoglycan was reduced in both strains, compared to the WT
strain, the peptidoglycan in the suppressor strain was more cross-linked than that in the
original ltaS mutant strain (Fig. 7A and B). Taken together, our data indicate that
deletion of ltaS leads to a significant reduction in the amount of cross-linked pepti-
doglycan in S. aureus. Inactivation of SgtB in a WT strain does not significantly affect the
amount of cross-linked peptidoglycan, as might be expected based on the observed
increase in oxacillin resistance. In an LTA-negative background strain, however, inacti-
vation of SgtB leads to an increase in peptidoglycan cross-linking, which might explain
why an LTA-negative strain can grow in the absence of this monofunctional pepti-
doglycan glycosyltransferase.
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DISCUSSION
The anionic LTA polymer is a core component of the cell wall that is essential for
survival, and a number of studies have shown its importance in various cell processes
(for a review, see reference 22). Phenotypes caused by the depletion of LTA in S. aureus
involve misplacement and incomplete formation of cell division septa and enlargement
of the cells, together ultimately leading to cell lysis (29, 34). However, how LTA
mediates these roles is still unknown. In previous work, it was shown that LtaS and
other core LTA synthesis proteins physically interact with early- and late-stage cell
division proteins, as well as with a number of peptidoglycan synthesis proteins (49).
These findings indicate that LTA synthesis enzymes might at least transiently be part of
multienzyme complexes, which might help to coordinate LTA synthesis with pepti-
doglycan synthesis and cell division (49).
We showed previously that S. aureus mutants with increased intracellular c-di-AMP
levels could survive without LTA (34). It is now thought that, at high c-di-AMP levels and
through the c-di-AMP-dependent regulation of potassium and osmolyte transporters,
the internal turgor pressure in the cell might be reduced, so that the compromised
LTA-depleted cell wall can sustain the internal pressure (34, 50–52). Indeed, as part of
the current study, we showed that the absence of LTA led to a sizable reduction in the
amount of cross-linked peptidoglycan in S. aureus (Fig. 7). This finding is consistent with
the idea that, in the absence of LTA, the cell wall is likely less able to sustain the high
internal turgor pressure, which might also contribute to the increased -lactam sensi-
tivity of LTA-negative strains observed in this study and previous studies (Table 2) (2,
34). The reason for the reduced amount of peptidoglycan cross-linking is currently not
TABLE 2MIC values for different antibiotics
Strain
MIC (g/ml)a of:
Lysostaphin Nisin Vancomycin Daptomycin
LAC* 0.125 (0.125, 0.125, 0.125) 16 (16, 16, 16) 4 (4, 4, 4) 16 (16, 16, 16)
S2-mazE 0.125 (0.125, 0.125, 0.125) 2–4 (2, 2, 4) 2 (2, 2, 2) 4–8 (8, 8, 4)
S4-sgtB 0.125–0.250 (0.125, 0.125, 0.25) 4 (4, 4, 4) 1 (1, 1, 1) 8–16 (16, 8, 8)
S7-vraT 0.500 (0.5, 0.5, 0.5) 2–4 (2, 2, 4) 4–8 (8, 4, 4) 8 (8, 8, 8)
LAC*sgtB::tn 0.125–0.250 (0.25, 0.125, 0.125) 16–32 (32, 16, 32) 4 (4, 4, 4) 16 (16, 16, 16)
LAC*sgtB::tn/pCL55 0.125–0.250 (0.125, 0.125, 0.25) 8–16 (16, 8, 16) 4 (4, 4, 4) 16 (16, 16, 16)
LAC*sgtB::tn/pCL55-sgtB 0.125 (0.125, 0.125, 0.125) 8–16 (8, 16, 16) 4–8 (4, 8, 4) 16 (16, 16, 16)
aThe MIC was defined as the antibiotic concentration that led to 90% growth inhibition, compared to growth without antibiotic. MICs were determined in triplicate.
The MIC ranges obtained are shown first, and individual MIC values of the replicate samples are shown in parentheses.
FIG 4 Growth complementation analysis using TSA plates with spot dilutions. (A) S. aureus strains LAC*/piTET,
LAC*/piTET-mazE, S2-mazE/piTET, and S2-mazE/piTET-mazE were grown overnight in TSB supplemented with
chloramphenicol and were washed twice with PBS, and serial dilutions were spotted on TSA plates supplemented
with 7.5 g/ml chloramphenicol, without or with 100 ng/ml Atet. (B) S. aureus strains LAC* (WT strain), LAC*/piTET,
LAC*/piTET-sgtB, S4-sgtB, S4-sgtB/piTET, and S4-sgtB/piTET-sgtB were grown and samples were prepared as
described for panel A but without chloramphenicol selection, and dilutions were spotted on TSA plates not
supplemented or supplemented with 200 ng/ml Atet (right). Representative plate images from three independent
experiments are shown.
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clear but could be due to mislocalization of PBPs in the absence of LTA or PBPs having
reduced enzyme activity since the proper ion homeostasis cannot be maintained within
the cell wall in the absence of LTA.
The aim of this study was to further elucidate the role of LTA in cell wall assembly
and potentially to identify additional proteins involved in the maintenance of cell wall
integrity. A suppressor screen followed by whole-genome sequencing revealed muta-
tions in genes coding for ClpX, SgtB, MazE, and VraT (Table 1) that could bypass the
requirement for LTA. Further experimentation indicated that the strain with the muta-
tion in vraT might not be an actual suppressor strain. In contrast, complementation
analysis and growth assays on agar plates containing the azo dye Congo red, which
prevents the growth of S. aureus by inhibiting the LtaS enzyme (44), confirmed that
inactivating mutations in sgtB and mazE could bypass the requirement for LTA. In a
previous study, it was found that an S. aureus clpX mutant readily acquired inactivating
mutations in ltaS, resulting in the generation of LTA-negative strains (2). Consistent with
FIG 5 Growth complementation analysis using TSA-sucrose plates with spot dilutions. (A) S. aureus strains
LAC*/piTET, LAC*/piTET-mazE, S2-mazE/piTET, and S2-mazE/piTET-mazE were grown overnight in TSB supple-
mented with chloramphenicol and were washed twice with PBS, and serial dilutions were spotted on TSA plates
with 40% sucrose supplemented with 7.5 g/ml chloramphenicol, without or with 100 ng/ml Atet. (B) S. aureus
strains LAC* (WT strain), LAC*/piTET, LAC*/piTET-sgtB, S4-sgtB, S4-sgtB/piTET, and S4-sgtB/piTET-sgtB were grown
and samples were prepared as described for panel A but without chloramphenicol selection, and dilutions were
spotted on TSA plates with 40% sucrose that were not supplemented or supplemented with 200 ng/ml Atet.
Representative plate images from three independent experiments are shown.
FIG 6 Growth and cell morphology of S. aureus strain LAC*sgtB::tn. (A) Bacterial growth curves. Overnight
cultures of LAC* (WT strain) and strain LAC*sgtB::tn (sgtB) were diluted in TSB to an OD600 of 0.05, and
growth was monitored for 10 h using a plate reader. The average OD600 values and SDs from three
independent experiments are plotted. (B) Microscopic analysis. S. aureus strains LAC* (WT strain) and
LAC*sgtB::tn (sgtB) were grown overnight in TSB or TSB supplemented with 40% sucrose, stained with
BODIPY-vancomycin, and viewed under a fluorescence microscope. (C) Susceptibility to Congo red.
Overnight cultures of LAC* (WT strain), the sgtBmutant strains LAC*sgtB::tn and LAC*sgtB::tn/pCL55, and the
complementation strain LAC*sgtB::tn/pCL55-sgtB were serially diluted, and aliquots were spotted on TSA
plates supplemented with 0.1% Congo red. For panels B and C, representative results from three indepen-
dent experiments are shown.
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the previous work, in this study we found a large deletion in clpX in one of our
LTA-negative suppressor strains (Table 1). ClpX is a protein-folding chaperon, which
recognizes and targets proteins for degradation to the ClpP protease component. In the
absence of ClpX, S. aureus cells become smaller, show increased production of auto-
lysins, and have a severe growth defect at temperatures of 30˚C or lower (2). The
introduction of loss-of-function mutations in the gene coding for the LTA synthase LtaS
in a clpX mutant alleviates some of these effects; this is perhaps due to LTA depletion
having the opposite effect, leading to increased cell size and decreased autolysis, as
reported in some previous publications (2, 31).
Mutations in the monofunctional glycosyltransferase SgtB were the most prevalent
mutations that arose in our suppressor screen. Previous studies showed that SgtB is not
essential for cell survival and, as reported in this study and a previous study, an sgtB
mutant strain does not show any obvious growth or morphological differences, com-
FIG 7 Peptidoglycan analysis of WT and mutant S. aureus strains. (A) HPLC profiles of mutanolysin-digested
peptidoglycan samples. Peptidoglycan was isolated and digested with mutanolysin (as described in Materials and
Methods) from the S. aureus LAC* strain (WT strain), the LAC*sgtB::tn strain (sgtB), and the LTA-negative suppressor
strain S4-sgtB following growth in TSB or from the S. aureus LAC* strain (WT strain), the LAC*sgtB::tn strain (sgtB),
and the LTA-negative suppressor strain S4-sgtB, as well as the original ltaS mutant strain (ANG2135), following
growth in TSB with 40% sucrose. Monomeric, dimeric, trimeric, and greater than trimeric peptidoglycan fragments
are indicated above the graphs, and representative profiles from three independent samples are shown. The
individual muropeptide peaks were labeled, where possible, with the numbers described by de Jonge et al. (48).
(B and C) Quantification of the different peptidoglycan peaks. The peaks corresponding to monomeric, dimeric,
trimeric, and greater than trimeric peptidoglycan fragments were integrated and quantified for the strains used in
panel A. The combined peak area was set to 100% for each strain, and the average values and SDs from the three
independent peptidoglycan isolations were plotted for the strains grown in TSB with sucrose (B) and for the strains
grown in TSB (C). Unpaired two-tailed Student’s t tests were used to determine statistically significant differences
in monomer, dimer, trimer, or greater than trimer fractions between WT and mutant strains. The P values obtained
were multiplied by Bonferroni correction factors of 3 (B) and 2 (C) because the WT peaks were compared to 3 or
2 different strains, respectively. Statistically significant differences are indicated by black asterisks. For panel B,
unpaired two-tailed Student’s t tests were also used to determine statistically significant differences in monomer,
dimer, trimer, or greater than trimer fractions between the ltaS mutant and the other three strains, and statistically
significant differences between the ltaS mutant and the S4-ltaS suppressor strain are shown with gray asterisks. *,
P  0.05; **, P  0.01; ***, P  0.001.
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pared to a WT strain, under standard growth conditions (Fig. 6) (15). Interestingly, we
found that the sgtB mutant strain LAC*sgtB::tn was 4-fold more resistant to the cell
wall-targeting antibiotic oxacillin and this phenotype could be complemented by
introduction of a WT copy of sgtB (Table 2). These results are in accordance with
previous reports, in which strains with mutations in genes that compensate for the lack
of LTA, such as gdpP and clpX mutant strains, also show increased oxacillin resistance
(2, 34).
The increased resistance of the sgtB mutant to oxacillin prompted us to investigate
the peptidoglycan structure of an sgtB mutant in more detail, as we hypothesized that,
in the absence of SgtB, changes such as increased cross-linking might be observed,
which could potentially explain the increased resistance. We could not detect any
obvious changes in the muropeptide profile of an sgtBmutant strain, compared to a WT
strain (Fig. 7). However, the original ltaS mutant strain showed a significant reduction
(around 30%) in the higher oligomeric cross-linked peptidoglycan (Fig. 7). Perhaps most
importantly, the peptidoglycan isolated from the sgtB ltaS double mutant S4-sgtB
suppressor strain showed an increase in peptidoglycan cross-linking, compared to the
original ltaS mutant strain (Fig. 7). We speculate that this increase in peptidoglycan
cross-linking could potentially strengthen the cell wall to better sustain the high
internal turgor pressure and might be at least partly responsible for the observed
growth improvement.
Bacterial two-hybrid studies have indicated that the S. aureus SgtB protein interacts
with SgtA, PBP1, PBP2, and PBP2A (15). Therefore, SgtB and the main glycosyltrans-
ferase PBP2 might compete for substrate during peptidoglycan biosynthesis, and
inactivation of the former might increase the substrate availability and activity of the
latter. This might then aid in the delivery of substrate to the transpeptidase domain of
the bifunctional PBP2 enzyme, resulting in increased cross-linking. Alternatively, SgtB
could also affect the function of PBP4, which has been shown to be responsible for
hyper-cross-linking of the staphylococcal peptidoglycan (53). Clearly, more experiments
are needed to clarify the complex nature of peptidoglycan biosynthesis in S. aureus and
the changes observed in the absence of LTA.
Mutations in MazE could potentially also be involved in changes in the cell wall
structure of S. aureus. The MazEF type II toxin-antitoxin system is part of the sigB
regulon and has been shown to be required for full activity of the alternative sigma
factor SigB (37). It has also been reported that overexpression of B causes cell wall
thickening in S. aureus and increased resistance to cell wall-targeting antibiotics (38).
Therefore, inactivation of MazE, as observed in one of our suppressor strains, could
potentially also affect cell wall homeostasis via its effect on SigB.
In summary, our results suggest that, in the absence of LTA, peptidoglycan in S.
aureus becomes less cross-linked, which might weaken the cell wall and cause it to
become less able to sustain the high internal turgor pressure, ultimately leading to cell
lysis. The suppressor mutations in sgtB (and perhaps also in some of the other genes
observed in our screen) help the cell survive this detrimental effect by altering and
strengthening the cell wall, likely allowing the cell wall to better withstand the high
internal turgor pressure.
MATERIALS AND METHODS
Bacterial strains and culture conditions. All bacterial strains used in this study are listed in
Table 3. Escherichia coli strains were cultured in lysogeny broth (LB) and Staphylococcus aureus strains
were cultured in TSB at 37°C with aeration, unless otherwise stated. When appropriate, the growth
medium was supplemented with antibiotics and inducers as follow: for E. coli cultures, 100 g/ml
ampicillin, 10 g/ml chloramphenicol, and 30 g/ml kanamycin; for S. aureus cultures, 10 g/ml chlor-
amphenicol for plasmid selection or 7.5 g/ml chloramphenicol for chromosomally integrated plasmid
selection, 10 g/ml erythromycin, and 90 g/ml kanamycin. The inducer Atet was used at a concentra-
tion of 100 or 200 ng/ml in agar plates and 50 ng/ml in broth.
Plasmid and strain construction. Strains and primers used in this study are listed in Tables 3 and
4, respectively. Strain LAC*sgtB::tn was generated by transduction using phage 85. In this manner, the
sgtB region containing a transposon insertion in sgtB was transduced from the Nebraska transposon
mutant library strain NE596 (45) into strain LAC*. Plasmids piTET-sgtB and piTET-mazE for Atet-inducible
expression of sgtB and mazE in S. aureus were generated by amplifying sgtB or mazE from LAC*
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chromosomal DNA using the primer pair ANG2268/ANG2269 or ANG2743/ANG2744, respectively. The
PCR products and plasmid piTET were digested with AvrII and SacII, ligated, and then transformed into
E. coli XL1-Blue, yielding strains XL1-Blue/piTET-sgtB (ANG3926) and XL1-Blue/piTET-mazE (ANG4727).
The plasmids were shuttled through E. coli strain IM08B (ANG3927 and ANG4728) and subsequently
electroporated into LAC*, yielding strains LAC*/piTET-sgtB (ANG4056) and LAC*/piTET-mazE (ANG4729),
or into the respective suppressor strains, yielding strains S4-sgtB/piTET-sgtB (ANG4058) and S2-mazE/
piTET-mazE (ANG4730). The plasmid pCL55-sgtB for complementation and expression of sgtB from its
native promoter was generated by amplifying the sgtB gene, including its native promoter region, from
LAC* chromosomal DNA using primers ANG2270 and ANG2271. The PCR product and plasmid pCL55
were digested with EcoRI and BamHI, ligated, and then transformed into E. coli XL1-Blue, yielding strain
XL1-Blue/pCL55-sgtB (ANG4708), shuttled through IM08B (ANG3923), and subsequently electroporated
into the sgtB mutant strain, yielding strain LAC*sgtB::tn/pCL55-sgtB (ANG4711). WT LAC* and mutant S.
aureus strains with the empty vectors piTET and pCL55 (Table 3) were used as control strains in several
experiments. The sequences of all plasmid inserts were verified by automated fluorescence sequencing
at GATC Biotechnology.
Bacterial growth curves. S. aureus LAC* and the indicated ltaS suppressor strains were grown
overnight in TSB containing the relevant antibiotic. The original ltaS mutant strains were grown in TSB
containing either 7.5% NaCl or 40% sucrose. Overnight cultures were washed three times in TSB and
diluted to a starting optical density at 600 nm (OD600) of 0.05. Cultures were incubated at 37°C with
aeration, and OD600 values were determined at 2-h intervals. WT LAC* and the sgtB mutant strain
LAC*sgtB::tn were grown overnight in TSB or TSB supplemented with 10 g/ml erythromycin. The next
TABLE 3 Bacterial strains used in this study
Species and strain Descriptiona Reference or source
Escherichia coli
XL1-Blue Cloning strain; Tetr; ANG127 Stratagene
IM08B E. coli-S. aureus shuttle strain; ANG3723 56
ANG3732 IM08B/pCL55 Ampr 52
ANG3926 XL1-Blue/piTET-sgtB Ampr This study
ANG3927 IM08B/piTET-sgtB Ampr This study
ANG3928 IM08B/piTET Ampr 57
ANG4708 XL1-Blue/pCL55-sgtB Ampr This study
ANG4707 IM08B/pCL55-sgtB Ampr This study
ANG4727 XL1-Blue/piTET-mazE Ampr This study
ANG4728 IM08B/piTET-mazE Ampr This study
Staphylococcus aureus
LAC* Erm-sensitive community-acquired MRSA LAC strain; ANG1575 58
NE596 JE2sgtB::tn, Nebraska Transposon Mutant Library strain; Ermr; ANG3930 45
ANG1961 LAC*gdpP::kan Kanr 34
ANG2134 LAC*ΔltaSN::erm pCN38, isolated on 7.5% NaCl; Camr Ermr 34
ANG2135 LAC*ΔltaSS::erm pCN38, isolated on 40% sucrose; Camr Ermr 34
ANG2137 LAC*ΔltaSN::erm suppressor S6, original colony; Ermr 34
ANG2140 LAC*ΔltaSS::erm suppressor S7, original colony; Ermr 34
ANG2143 LAC*ΔltaSS::erm suppressor S8, original colony; Ermr 34
ANG2434 LAC*ΔltaSS::erm suppressor with gdpP mutation, pass 4 (short: US3); Ermr 34
ANG3694 LAC*ΔltaSS::erm suppressor S1, original colony; Ermr This study
ANG3698 LAC*ΔltaSS::erm suppressor S2, original colony; Ermr This study
ANG3703 LAC*ΔltaSS::erm suppressor S3, original colony; Ermr This study
ANG3707 LAC*ΔltaSS::erm suppressor S4, original colony; Ermr This study
ANG3711 LAC*ΔltaSS::erm suppressor S1, pass 4 (short: S1-sgtB); Ermr This study
ANG3712 LAC*ΔltaSS::erm suppressor S2, pass 4 (short: S2-mazE); Ermr This study
ANG3713 LAC*ΔltaSN::erm suppressor S3, pass 4 (short: S3-clpX); Ermr This study
ANG3714 LAC*ΔltaSN::erm suppressor S4, pass 4 (short: S4-sgtB); Ermr This study
ANG3716 LAC*ΔltaSN::erm suppressor S6, pass 4 (short: S6); Ermr This study
ANG3717 LAC*ΔltaSS::erm suppressor S7, pass 4 (short: S7-vraT); Ermr This study
ANG3718 LAC*ΔltaSS::erm suppressor S8, pass 4 (short: S8-sgtB); Ermr This study
ANG4054 LAC*/piTET Camr 57
ANG4056 LAC*/piTET-sgtB Camr This study
ANG4057 S4-sgtB/piTET Ermr Camr This study
ANG4058 S4-sgtB/piTET-sgtB Ermr Camr This study
ANG4059 LAC*sgtB::tn Ermr This study
ANG4710 LAC*sgtB::tn/pCL55 Ermr Camr This study
ANG4711 LAC*sgtB::tn/pCL55-sgtB Ermr Camr This study
ANG4725 S2-mazE/piTET Ermr Camr This study
ANG4729 LAC*/piTET-mazE Camr This study
ANG4730 S2-mazE/piTET-mazE Ermr Camr This study
aTetr, tetracycline resistant; Ampr, ampicillin resistant; Erm, erythromycin; Ermr, erythromycin resistant; Kanr, kanamycin resistant; Camr, chloramphenicol resistant.
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day, bacteria were washed three times in TSB and diluted to a starting OD600 of 0.05, and 200 l was
placed in a 96-well microtiter plate. Growth was monitored for 10 h using a SPECTROstar Nano plate
reader (BMG Labtech). All growth curves were determined in triplicate, with average values and standard
deviations (SDs) being plotted.
Fluorescence microscopy analysis. Cells from 1ml of overnight culture were collected by centrif-
ugation and washed three times in phosphate-buffered saline (PBS) (pH 7.4), and 150 l of the cell
suspensions was applied to polylysine (0.1% [wt/vol])-treated coverslips. The coverslips coated with the
bacteria were incubated for 20 min with 100 l of a 1-g/ml boron-dipyrromethene (BODIPY)-
vancomycin (Molecular Probes) solution in water, washed, and mounted on glass slides containing 20 l
Vectashield (Vector Laboratories). Slides were viewed under a Zeiss Axio Imager A2, using a green
fluorescent protein (GFP) filter set, and images were captured with an AxioCam MRc Rev.3 camera and
analyzed using Zen Pro 2012 SP2 software. The experiment was performed in triplicate.
MIC determination. Overnight cultures of the WT strain, the sgtB mutant, and the complementation
strain, as well as the indicated suppressor strains, were grown overnight in TSB. The next day, cultures
were adjusted to an OD600 of 0.05 in TSB, and 100-l aliquots of the suspensions were incubated in
96-well plates with 2-fold dilutions of various antimicrobials, at the following starting concentrations:
oxacillin, 500 g/ml or 1 g/ml as appropriate; daptomycin, 32 g/ml; lysostaphin, 2 g/ml; vancomycin,
32 g/ml; nisin, 64 g/ml. Oxacillin- and daptomycin-containing wells were supplemented with 2%
(wt/vol) NaCl and 0.23 mM CaCl2, respectively. Plates were incubated for 24 h at 37°C, with shaking at
500 rpm. MICs were determined as the concentrations of antibiotic at which growth was inhibited by
90%, compared to growth without the antibiotic.
LTA detection by Western blotting. LTA extraction and detection by Western blotting were
performed as described previously (54). Briefly, samples were prepared from 1-ml overnight cultures
normalized based on OD600 readings, i.e., cells from 1-ml cultures with an OD600 of 6 were suspended in
90 l 2 SDS protein sample buffer. Ten-microliter aliquots of these samples were separated on 15%
SDS-polyacrylamide gels, and the material was subsequently transferred to polyvinylidene difluoride
(PVDF) membranes. LTA was detected using a polyglycerolphosphate-specific LTA monoclonal antibody
(Hycult Biotechnology) at a 1:4,000 dilution and a horseradish peroxidase (HRP)-conjugated anti-mouse
IgG antibody (Cell Signaling Technologies, USA) at a 1:10,000 dilution. The blots were developed by
enhanced chemiluminescence (ECL) using the Clarity Western ECL blotting substrate (Bio-Rad) and were
imaged using the ChemiDoc Touch imaging system (Bio-Rad). Western blots were performed in triplicate,
and representative results are shown.
Detection of WTA by Alcian blue/silver staining. Flasks with 60 ml TSB supplemented with the
appropriate antibiotics were inoculated with single colonies of WT LAC* and different suppressor strains,
and the cultures were incubated overnight (18 h) at 37°C, with shaking. The original ltaS mutant was
grown in TSB supplemented with 40% sucrose and was incubated 6 to 8 h longer. Cells from an OD600
equivalent of 120 were harvested by centrifugation, and the bacterial pellet was stored at 20°C for
further processing. WTA extraction and detection by Alcian blue/silver staining following SDS-PAGE
analysis was performed as described by Covas et al. (55). Briefly, cells were washed in 20 ml buffer 1
[50 mM 2-(N-morpholino)ethanesulfonic acid (MES) (pH 6.5)], resuspended in 20 ml buffer 2 (buffer 1 with
4% [wt/vol] SDS), and boiled for 60 min. Next, the cells were washed with 20 ml buffer 2 and, after
transfer to 2.0-ml reaction tubes, washed once more with 1.6 ml buffer 2, 1.6 ml buffer 3 (buffer 1 with
2% [wt/vol] NaCl), and finally 1.6 ml buffer 1. The samples were suspended in 1.6 ml buffer 4 (20 mM
Tris-HCl [pH 8.0], 0.5% [wt/vol] SDS) and incubated for 4 h at 50°C, with shaking, following the addition
of 2 l of proteinase K solution (20 mg/ml) from Tritirachium album. Next, the cells were collected by
centrifugation, washed once with 1.6 ml buffer 3, and washed three times with 1.6 ml of water. To release
WTA, the pellets were suspended in 1 ml of 0.1 mM NaOH, and the samples were incubated for 16 h at
25°C. Next, the samples were centrifuged, 30 l of the supernatant (containing WTA) was separated on
native Tris-Tricine polyacrylamide gels, and WTA was visualized by Alcian blue/silver staining (55).
TABLE 4 Primers used in this study
Primer identification Primer name Sequencea
ANG2229 sausa300_1867 Fw seq GAAGCATTTCAAATTCAATGTGCAAG
ANG2230 sausa300_1867 Rv seq GAAGCATTTCAAATTCAATGTGCAAG
ANG2231 sgtB Fw seq GTCGTCTCTATTGGCATTTAATAGGG
ANG2232 sgtB Rv seq AATAATGAAGTACTAATCAAGTGGC
ANG2233 sausa300_1254 Fw seq CATTTTGAAGAAAGGATTAATCAA
ANG2234 sausa300_1254 Rv seq AATAATGAAGTACTAATCAAGTGGC
ANG2235 clpX Fw seq GAAGGAACTAAAGAAGATTAATCTTC
ANG2236 clpX Rv seq CTGGATATTGTTCTTCTTTTACTGCAC
ANG2268 5-AvrII-sgtB-pCL55iTet CATGCCTAGGTTAAAAGAAGGAGCAAACGCATG
ANG2269 3-SacII-sgtB-pCL55iTet CATGCCGCGGTTAACGATTTAATTGTGACATAGCC
ANG2409 5- EcoRI-promSgtB-pCL55 CATGGAATTCAAGTATTGTGGTTATCGATTG
ANG2410 3- BamH1-promSgtB-pCL55 CATGGGATCCTTAACGATTTAATTGTGACATAGCC
ANG2740 5-mazE SNP seq AGATAATCATAGAGAAAGTCCACAGTCG
ANG2741 3-mazE SNP seq TAAGTACGTCAGTTTTTCTTTCAATCGT
ANG2743 5-AvrII-mazE-pCL55iTet CATGCCTAGGGGAATCAATTGGAGGTTCTCATATG
ANG2744 3-SacII-mazE-pCl55iTet CATGCCGCGGTCATTCATTCGTTGAATTAGAAGATAAATATG
aRestriction site sequences are underlined.
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Whole-genome sequencing. WT LAC*, LAC*ΔltaSN, LAC*ΔltaSS, and indicated suppressor strains
were cultured overnight at 37°C, cells were harvested, and genomic DNA was extracted. Genome
sequencing was performed by MicrobesNG (University of Birmingham), using an Illumina platform and
a 250-bp paired-end read kit. Sequence analysis was performed using the CLC Genomics Workbench
software package. First, the LAC* reads were aligned against the published USA300 FPR3757 genome
sequence (RefSeq accession number NC_007793.1) and assembled into a reference contig, and the
USA300 FPR3757 annotation was transferred onto the LAC* sequence. Next, the Illumina reads for the
original ltaS mutant strains LAC*ΔltaSS and LAC*ΔltaSN, as well as the 7 different suppressor strains,
were mapped onto the assembled LAC* sequence, and high-frequency (65%) and good-quality base
changes were identified using the CLC Genomics Workbench software package. Genomic alterations
found in the suppressor strains but not present in the original ltaS mutant strain are summarized in
Table 1.
Peptidoglycan isolation and analysis. Overnight cultures of S. aureus strains LAC*, S4-sgtB, and
LAC*sgtB::tn were prepared in TSB or TSB supplemented with 40% sucrose, and cultures of the original
ltaS mutant strain LAC*ΔltaSN (ANG2134) were prepared in TSB supplemented with 40% sucrose. The
next day, cells were back-diluted in 2 liters of the same growth medium, to an OD600 of 0.05. The cultures
were grown at 37°C until they reached an OD600 of approximately 1.5 and were cooled on ice, and cells
were collected by centrifugation. Peptidoglycan was purified and digested with mutanolysin as de-
scribed previously (34, 48). High-performance liquid chromatography (HPLC) analysis of the digested
peptidoglycan material was performed as described previously (48), and the muropeptide profiles were
determined in triplicate for each strain and growth condition. For the quantification of monomeric,
dimeric, trimeric, and higher oligomeric peptidoglycan material, the peaks were integrated. The total
peak area for each muropetide profile was determined and set to 100%, the percentages of monomeric,
dimeric, trimeric, and higher oligomeric peaks were calculated, and the average values and SDs from the
three profiles were determined and plotted.
c-di-AMP quantification by competitive ELISA. Five-milliliter aliquots of TSB were inoculated with
single colonies of S. aureus LAC* (WT strain), strain LAC* gdpP::kan, strain US3 (LAC*ΔltaSS::erm suppressor
with a mutation in gdpP), and the different LTA-negative suppressor strains, and the tubes were
incubated for 8 h at 37°C. Next, the cultures were back-diluted in 10 ml TSB to an OD600 of 0.05 and were
grown for 15 h at 37°C. Bacterial cells from these cultures were collected by centrifugation, cell lysates
were prepared, and the cellular c-di-AMP levels were determined using a previously described compet-
itive ELISA method (35, 36). However, instead of determining c-di-AMP levels based on a standard curve,
the A490 values were directly compared. To this end, the A490 readings obtained for samples derived from
the WT strain were set to 100%, and percentage values were calculated for the samples derived from the
other strains. Thee independent experiments were performed, with three technical replicates, and the
average values and SDs for the percentage values were determined for each strain, compared to the WT
strain. Of note, since this was a competitive ELISA, decreases in A490 readings represented increases in
cellular c-di-AMP levels.
Accession number(s). The Illumina short read for the WT LAC* was published previously (35) and has
been deposited in the European Nucleotide Archive under study accession number PRJEB14759. The
Illumina reads for the ltaS mutants and the ltaS suppressor strains were deposited in the European
Nucleotide Archive under study accession number PRJEB29420.
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